ID G-401 AC CVCL_0270 SY G401; G 401 DR BTO; BTO_0002586 DR CLO; CLO_0003434 DR EFO; EFO_0002179 DR MCCL; MCC:0000161 DR CLDB; cl1409 DR 4DN; 4DNSR6XERO32 DR ArrayExpress; E-MTAB-38 DR ArrayExpress; E-MTAB-783 DR ArrayExpress; E-MTAB-2770 DR ArrayExpress; E-MTAB-3610 DR ATCC; CRL-1441 DR BCRJ; 0418 DR BioSample; SAMN03470969 DR BioSample; SAMN03472819 DR BioSample; SAMN10987919 DR cancercelllines; CVCL_0270 DR CCRID; 1101HUM-PUMC000034 DR Cell_Model_Passport; SIDM00856 DR ChEMBL-Cells; CHEMBL3308394 DR ChEMBL-Targets; CHEMBL613509 DR Cosmic; 683682 DR Cosmic; 802044 DR Cosmic; 802245 DR Cosmic; 907299 DR Cosmic-CLP; 907299 DR DepMap; ACH-000096 DR ECACC; 87042204 DR EGA; EGAS00001000978 DR ENCODE; ENCBS062JBT DR ENCODE; ENCBS432GBV DR ENCODE; ENCBS629BMK DR ENCODE; ENCBS659PBH DR FANTOM5_SSTAR; 10809-111A8 DR GDSC; 907299 DR GEO; GSM827165 DR GEO; GSM887017 DR GEO; GSM888086 DR GEO; GSM1669799 DR GEO; GSM1676299 DR GEO; GSM1701634 DR GEO; GSM2033123 DR GEO; GSM2033124 DR GEO; GSM2033125 DR GEO; GSM2033126 DR GEO; GSM2033127 DR GEO; GSM2033128 DR GEO; GSM2409659 DR GEO; GSM2409660 DR GEO; GSM2409661 DR GEO; GSM2409662 DR GEO; GSM2409663 DR GEO; GSM2495985 DR GEO; GSM2787352 DR IARC_TP53; 21334 DR IGRhCellID; G401 DR JCRB; JCRB9065 DR LiGeA; CCLE_546 DR LINCS_LDP; LCL-1511 DR PharmacoDB; G401_374_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_0270 DR PubChem_Cell_line; CVCL_0270 DR TOKU-E; 1303 DR Wikidata; Q54835347 RX PubMed=8382007; RX PubMed=9671307; RX PubMed=10397258; RX PubMed=10602515; RX PubMed=20164919; RX PubMed=20215515; RX PubMed=22460905; RX PubMed=25877200; RX PubMed=26351324; RX PubMed=27397505; RX PubMed=28945250; RX PubMed=30894373; RX PubMed=30924592; RX PubMed=31068700; RX PubMed=31978347; RX PubMed=35839778; WW Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-286.html WW Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/kidney-cancer-xenograft/g401-xenograft-model/ CC Problematic cell line: Misclassified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (PubMed=8382007; PubMed=30924592). CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Caucasian. CC Microsatellite instability: Stable (MSS) (Sanger). CC Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307; PubMed=10602515; PubMed=28945250). CC Omics: Genomics; ChIP-seq; H3K27ac. CC Omics: Genomics; ChIP-seq; H3K27me3. CC Omics: Genomics; ChIP-seq; H3K4me3. CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=2.48%; Native American=0.75%; East Asian, North=2.12%; East Asian, South=0.55%; South Asian=8.63%; European, North=29.24%; European, South=56.23% (PubMed=30894373). CC Derived from site: In situ; Kidney; UBERON=UBERON_0002113. ST Source(s): ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065; PubMed=25877200 ST Amelogenin: X,Y ST CSF1PO: 11,13 ST D13S317: 9,14 ST D16S539: 12 ST D18S51: 14 ST D19S433: 13,14 ST D21S11: 31,32.2 (CCRID=1101HUM-PUMC000034) ST D21S11: 31,32.2,33.2 (ATCC=CRL-1441; PubMed=25877200) ST D2S1338: 18,24 ST D3S1358: 16,18 ST D5S818: 13 ST D7S820: 11,14 ST D8S1179: 13,14 ST FGA: 24,26,27 (ATCC=CRL-1441) ST FGA: 24,27 (CCRID=1101HUM-PUMC000034; PubMed=25877200) ST Penta D: 10,11 ST Penta E: 7 ST TH01: 8,9.3 (ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065) ST TH01: 9.3 (PubMed=25877200) ST TPOX: 8,11 (ATCC=CRL-1441; CCRID=1101HUM-PUMC000034; Cosmic-CLP=907299; ECACC=87042204; JCRB=JCRB9065) ST TPOX: 11 (PubMed=25877200) ST vWA: 16 DI NCIt; C8715; Rhabdoid tumor of the kidney DI ORDO; Orphanet_69077; Rhabdoid tumor OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 3M CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 45 CH CVCL_QW55 ! G-401 BAF47 CH CVCL_J252 ! G-401-Luc CH CVCL_L269 ! G401.6 // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=30924592; DOI=10.1002/pbc.27741; RA Pritchard-Jones, Kathryn RA Perotti, Daniela RT "WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell RT lines."; RL Pediatr. Blood Cancer 66:e27741.1-e27741.2(2019). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=8382007; PMCID=PMC1886739; RA Garvin, Abbott Julian RA Re, Gian G. RA Tarnowski, Betty I. RA Hazen-Martin, Debra J. RA Sens, Donald A. RT "The G401 cell line, utilized for studies of chromosomal changes in RT Wilms' tumor, is derived from a rhabdoid tumor of the kidney."; RL Am. J. Pathol. 142:375-380(1993). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). // RX PubMed=26351324; DOI=10.1158/1535-7163.MCT-15-0074; PMCID=PMC4636476; RA Teicher, Beverly A. RA Polley, Eric C. RA Kunkel, Mark W. RA Evans, David RA Silvers, Thomas E. RA Delosh, Rene M. RA Laudeman, Julie RA Ogle, Chad RA Reinhart, Russell RA Selby, Michael RA Connelly, John RA Harris, Erik RA Monks, Anne RA Morris, Joel RT "Sarcoma cell line screen of oncology drugs and investigational agents RT identifies patterns associated with gene and microRNA expression."; RL Mol. Cancer Ther. 14:2452-2462(2015). // RX PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027; RA Barretina, Jordi Ginesta RA Caponigro, Giordano RA Stransky, Nicolas RA Venkatesan, Kavitha RA Margolin, Adam A. RA Kim, Sungjoon RA Wilson, Christopher J. RA Lehar, Joseph RA Kryukov, Gregory V. RA Sonkin, Dmitriy RA Reddy, Anupama RA Liu, Manway RA Murray, Lauren RA Berger, Michael F. RA Monahan, John E. RA Morais, Paula RA Meltzer, Jodi RA Korejwa, Adam RA Jane-Valbuena, Judit RA Mapa, Felipa A. RA Thibault, Joseph RA Bric-Furlong, Eva RA Raman, Pichai RA Shipway, Aaron RA Engels, Ingo H. RA Cheng, Jill RA Yu, Guo-Ying K. RA Yu, Jian-Jun RA Aspesi, Peter Jr. RA de Silva, Melanie RA Jagtap, Kalpana RA Jones, Michael D. RA Wang, Li RA Hatton, Charles RA Palescandolo, Emanuele RA Gupta, Supriya RA Mahan, Scott RA Sougnez, Carrie RA Onofrio, Robert C. RA Liefeld, Ted RA MacConaill, Laura Eleanor RA Winckler, Wendy RA Reich, Michael RA Li, Nan-Xin RA Mesirov, Jill P. RA Gabriel, Stacey B. RA Getz, Gad RA Ardlie, Kristin RA Chan, Vivien RA Myer, Vic E. RA Weber, Barbara L. RA Porter, Jeff RA Warmuth, Markus RA Finan, Peter RA Harris, Jennifer L. RA Meyerson, Matthew Langer RA Golub, Todd Robert RA Morrissey, Michael P. RA Sellers, William Raj RA Schlegel, Robert RA Garraway, Levi Alexander RT "The Cancer Cell Line Encyclopedia enables predictive modelling of RT anticancer drug sensitivity."; RL Nature 483:603-607(2012). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=9671307; DOI=10.1038/28212; RA Versteege, Isabella RA Sevenet, Nicolas RA Lange, Julian RA Rousseau-Merck, Marie-Francoise RA Ambros, Peter F. RA Handgretinger, Rupert RA Aurias, Alain RA Delattre, Olivier RT "Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer."; RL Nature 394:203-206(1998). // RX PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254; RA Nusinow, David Paul RA Szpyt, John RA Ghandi, Mahmoud RA Rose, Christopher M. RA McDonald, E. Robert 3rd RA Kalocsay, Marian RA Jane-Valbuena, Judit RA Gelfand, Ellen T. RA Schweppe, Devin Karl RA Jedrychowski, Mark P. RA Golji, Javad RA Porter, Dale A. RA Rejtar, Tomas RA Wang, Y. Karen RA Kryukov, Gregory V. RA Stegmeier, Frank RA Erickson, Brian K. RA Garraway, Levi Alexander RA Sellers, William Raj RA Gygi, Steven P. RT "Quantitative proteomics of the Cancer Cell Line Encyclopedia."; RL Cell 180:387-402.e16(2020). // RX PubMed=10397258; RA Rousseau-Merck, Marie-Francoise RA Versteege, Isabella RA Legrand, Isabelle RA Couturier, Jerome RA Mairal, Aline RA Delattre, Olivier RA Aurias, Alain RT "hSNF5/INI1 inactivation is mainly associated with homozygous RT deletions and mitotic recombinations in rhabdoid tumors."; RL Cancer Res. 59:3152-3156(1999). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113; RA Bignell, Graham Robert RA Greenman, Christopher D. RA Davies, Helen R. RA Butler, Adam P. RA Edkins, Sarah RA Andrews, Jenny M. RA Buck, Gemma RA Chen, Lina RA Beare, David RA Latimer, Calli RA Widaa, Sara RA Hinton, Jonathan RA Fahey, Ciara RA Fu, Bei-Yuan RA Swamy, Sajani RA Dalgliesh, Gillian L. RA Teh, Bin Tean RA Deloukas, Panos RA Yang, Feng-Tang RA Campbell, Peter J. RA Futreal, P. Andrew RA Stratton, Michael Rudolf RT "Signatures of mutation and selection in the cancer genome."; RL Nature 463:893-898(2010). // RX PubMed=10602515; DOI=10.1038/sj.onc.1203168; RA DeCristofaro, Marc F. RA Betz, Bryan L. RA Wang, Wei-Dong RA Weissman, Bernard E. RT "Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and RT primary rhabdomyosarcomas but not Wilms' tumors."; RL Oncogene 18:7559-7565(1999). // RX PubMed=28945250; DOI=10.1038/ng.3958; PMCID=PMC5803080; RA Nakayama, Robert T. RA Pulice, John L. RA Valencia, Alfredo M. RA McBride, Matthew J. RA McKenzie, Zachary M. RA Gillespie, Mark A. RA Ku, Wai Lim RA Teng, Ming-Xiang RA Cui, Kai-Rong RA Williams, Robert T. RA Cassel, Seth H. RA Qing, He RA Widmer, Christian J. RA Demetri, George Daniel RA Irizarry, Rafael Angel RA Zhao, Ke-Ji RA Ranish, Jeffrey A. RA Kadoch, Cigall RT "SMARCB1 is required for widespread BAF complex-mediated activation of RT enhancers and bivalent promoters."; RL Nat. Genet. 49:1613-1623(2017). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). //